Merck | MRK - Операционный доход





Операционный доход Изменить Дата
Adidas EUR 574M 131M 2026-06
Adyen EUR 570.31M 56.8M 2026-06
Akzo Nobel EUR 251M 3M 2026-06
Alcon AG USD 44M 253M 2026-06
Amadeus IT EUR 478.3M 12.8M 2026-06
Amarin USD -2.26M 564K 2025-12
AstraZeneca USD 3.16B 3.95B 2026-06
BASF EUR 1.43B 31M 2026-06
Bayer EUR 827M 2.7B 2026-06
Beiersdorf EUR 504M 312M 2025-12
Covestro EUR -324M 5.72B 2025-12
Danone EUR 1.86B 6M 2026-06
Fresenius EUR 719M 118M 2026-06
Fresenius Medical Care EUR 537.27M 269.27M 2026-06
Genmab DKK 407M 182M 2026-06
Givaudan CHF 610M 149M 2025-12
GlaxoSmithKline GBP 2.6B 312M 2026-06
GRIFOLS EUR 329M 80M 2026-06
Henkel EUR 1.64B 220M 2026-06
Hikma Pharmaceutical USD 348M 161M 2025-12
Infineon EUR 606M 120M 2026-06
Lakefront Biotherapeutics EUR -43.51M 20.19M 2026-06
Linde USD 2.38B 129M 2026-03
Lonza CHF 673M 243M 2025-06
Merck EUR 1.1B 51M 2026-06
Novartis USD 4.75B 515M 2026-06
Philips EUR 610M 308M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sanofi EUR 2.38B 449M 2026-06
UCB EUR 1.29B 571M 2025-12